Loading organizations...
Loading organizations...
We're building the one-stop-shop care platform for Alzheimer's…
Craniometrix has raised $7.5M across 2 funding rounds.
Key people at Craniometrix.
Craniometrix was founded in 2021 by Nikhil Patel (Founder).
Craniometrix has raised $7.5M in total across 2 funding rounds.
Alzheimer’s is tough. And while there is no cure, getting help should be 100x easier than it is today. We’ve raised over $6 million to solve that problem.
When someone is going through the disease, there are many different things they need help with (i.e. memory issues, depression, fall risk, safety in the home, etc). The primary person responsible for that care is one of the patient’s loved ones – usually a child or a spouse.
That’s a really difficult thing for the loved one to do. It’s stressful, time consuming, and difficult. If we can make their lives easier, we can not only improve their experience but also create better patient outcomes.
We’re building the world’s first one-stop-shop, d2c care platform for Alzheimer’s, starting by optimizing the care monitoring, management, and intervention processes.
Key people at Craniometrix.
Craniometrix was founded in 2021 by Nikhil Patel (Founder).
Craniometrix has raised $7.5M in total across 2 funding rounds.
Craniometrix's investors include Cathexis Ventures, Neil Sequeira, J-Ventures, Olive Tree Capital, Quiet Capital, Rebel Fund, Y Combinator.
Craniometrix is a telemedicine platform dedicated to building the world’s first one-stop-shop direct-to-consumer (D2C) care platform specifically for Alzheimer's and dementia care. It serves patients, caregivers, and healthcare providers by offering personalized, AI-driven digital diagnostics, care management tools, and 24/7 support. The platform integrates with Medicare’s GUIDE program to provide cost-efficient, comprehensive dementia care navigation that improves patient outcomes while supporting caregivers and unlocking new revenue streams for providers[1][2][4].
Founded by CEO Nikhil Patel, a Yale alumnus with a background in hedge funds and Goldman Sachs trading algorithms, Craniometrix emerged from a personal connection to Alzheimer's when a relative was diagnosed. This inspired Patel to pivot from finance to healthcare technology, focusing on early detection and care management for dementia. The company was founded around 2021-2022 and has since raised over $6 million from investors including Y Combinator, Quiet Capital, and Defy.vc. Early traction includes partnerships with Johns Hopkins MIND at Home program and achieving nearly $2 million in revenue by 2024[2][3][4][7].
Craniometrix rides the growing trend of telemedicine and AI-driven healthcare solutions, addressing the urgent need for scalable, patient-centered dementia care amid an aging population. The timing is critical as Medicare introduces new reimbursement models like GUIDE, incentivizing proactive, coordinated care. By leveraging technology to empower caregivers and reduce hospitalizations, Craniometrix influences the broader healthcare ecosystem by demonstrating how AI and digital platforms can improve chronic disease management and reduce costs[1][3][6][7].
Looking ahead, Craniometrix aims to expand its subscription offerings to include real-time doctor access and comprehensive symptom management tools, further easing the burden on caregivers and improving patient quality of life. Trends such as increased Medicare support for home-based care, advances in AI diagnostics, and growing demand for caregiver resources will shape its trajectory. As it scales, Craniometrix could redefine standards for dementia care, shifting the paradigm toward more accessible, data-driven, and compassionate support systems[3][4][7][8]. This aligns with its mission to revolutionize dementia care by making it easier, more effective, and more dignified for patients and families alike.
Craniometrix has raised $7.5M across 2 funding rounds. Most recently, it raised $6.0M Seed in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 10, 2022 | $6.0M Seed | Cathexis Ventures, Neil Sequeira, J-Ventures, Olive Tree Capital, Quiet Capital, Rebel Fund, Y Combinator | |
| Mar 2, 2022 | $1.5M Pre-Seed |
